Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Shares Outstanding (2010 - 2026)

Exelixis (EXEL) posted quarterly Shares Outstanding (Entity) of $253.7 million for Q2 2026, down 7.76% year-over-year from $275.0 million in Q2 2025, and down 3.35% quarter-over-quarter from $262.5 million in Q1 2026.

Analysis

Exelixis (EXEL) Shares Outstanding (2010 - 2026) Analysis & Trends

Exelixis' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $253.7 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Entity) fell 7.76% year-over-year to $253.7 million; the TTM figure through Apr 2026 stood at $253.7 million (down 7.76% YoY), while the FY2026 annual figure was $262.5 million, down 6.83% from the prior year.
  • Shares Outstanding (Entity) for Q2 2026 stood at $253.7 million, down from $262.5 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $325.0 million in Q1 2023, with the low at $253.7 million in Q2 2026.
  • The 5-year median for Shares Outstanding (Entity) is $295.0 million (2024), against an average of $295.6 million.
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) climbed 2.24% in 2022, then decreased 10.94% in 2024.
  • Exelixis' Shares Outstanding (Entity) stood at $324.0 million in 2022, then decreased by 6.53% to $302.8 million in 2023, then decreased by 5.62% to $285.8 million in 2024, then fell by 6.19% to $268.1 million in 2025, then dropped by 5.37% to $253.7 million in 2026.
  • Business Quant data shows EXEL's Shares Outstanding (Entity) at $253.7 million in Q2 2026, $262.5 million in Q1 2026, and $268.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 250.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 250.81 Mn
Apr 3, 2026 258.33 Mn
Jan 2, 2026 271.57 Mn
Oct 3, 2025 268.42 Mn
Jul 4, 2025 272.58 Mn
Apr 4, 2025 278.80 Mn
Jan 3, 2025 290.03 Mn
Sep 27, 2024 285.62 Mn
Jun 28, 2024 289.22 Mn
Mar 29, 2024 300.76 Mn
Dec 29, 2023 318.15 Mn
Sep 29, 2023 315.50 Mn
Jun 30, 2023 324.21 Mn
Mar 31, 2023 324.42 Mn
Dec 30, 2022 321.53 Mn
Sep 30, 2022 322.15 Mn
Jul 1, 2022 321.12 Mn
Apr 1, 2022 319.58 Mn
Dec 31, 2021 314.88 Mn
Oct 1, 2021 315.38 Mn